Clinical Trials Directory

Trials / Completed

CompletedNCT00859872

Efficacy and Safety of Risperidone Oral Solution Combination Clonazepam Versus Haloperidol Intramuscular (IM) Injection for Treatment of Acute Psychotic Agitation in Schizophrenia

Efficacy and Safety of Risperidone Oral Solution Combination Clonazepam Versus Haloperidol IM Injection for Treatment of Acute Psychotic Agitation in Schizophrenia

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
198 (actual)
Sponsor
Central South University · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

This is a multi-centre, open, randomized, haloperidol-referenced, 47 days two treatment sessions, parallel-group study. After screening period, eligible subjects will be entered 5 days treatment session I to compare the efficacy between risperidone oral solution combination clonazepam oral and haloperidol IM injection on controlling psychotic agitation, then will be followed by 6 additional weeks treatment session II for exploring the effect of medicine switching from IM injection to oral.

Detailed description

Acute psychotic agitation is a common problem in many patients with schizophrenia that includes agitation, aggression, excitement and violence. An investigation showed that about 26% psychotic patients were brought to the psychiatric emergency room because of the psychotic agitation symptoms. The primary objective is to compare the efficacy between risperidone oral solution combination clonazepam oral and haloperidol IM injection on controlling psychotic agitation in patients of acute schizophrenia and schizophrenic-affective disorder. The secondary objectives are: (1) to explore the possibility of decreasing efficacy of acute 6 weeks treatment from IM injection to oral; (2) to compare the safety between risperidone oral solution combination clonazepam oral and haloperidol IM injection.

Conditions

Interventions

TypeNameDescription
DRUGrisperidone oral solutionrisperidone oral solution (2-6mg/d) combination clonazepam (4-8mg/d) oral
DRUGhaloperidolhaloperidol IM injection (5-20mg/d)

Timeline

Start date
2008-08-01
Primary completion
2009-03-01
Completion
2009-03-01
First posted
2009-03-11
Last updated
2009-08-03

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT00859872. Inclusion in this directory is not an endorsement.

Efficacy and Safety of Risperidone Oral Solution Combination Clonazepam Versus Haloperidol Intramuscular (IM) Injection (NCT00859872) · Clinical Trials Directory